Speaker Profile

Ph.D., CEO, SpIntellx, Inc.

Biography
S. Chakra Chennubhotla was a tenured Associate Professor in the Department of Computational and Systems Biology at the University of Pittsburgh. The focus of his research group at Pitt was in building computational and systems pathology models to investigate the molecular origins of human epithelial malignancies from patient primary solid tumor pathology tissue sections. With an eye on translational medicine, his group pursued computer vision, machine learning and AI models that are explainable and spatially driven to capture the spatial hierarchy of intratumor heterogeneity, a key factor in predicting disease progression and therapeutic responses. Chakra co-founded SpIntellx to actualize the translational potential of these Pitt IP-fueled platforms. Chakra’s experience encompasses years in both industry and academia. He was the lead PI on several NIH and NSF grants covering broad areas of bioimaging, biophysics, computational and systems pathology. He holds several patents and has published extensively.


AI & Data Science Showcase:
SpIntellx, Inc.

Spatial Intelligence and Explainable AI Inform Therapeutic Strategies and Clinical Decisions for Precision Medicine

Spatial Intelligence and Explainable AI for Precision Medicine Pathology
SpIntellx is disrupting the precision medicine pathology market by creating unprecedented predictive knowledge from patient disease samples creating a new paradigm for personalized therapeutic strategies, identification of novel targets for drug discovery, advanced prognostics and companion diagnostics, intelligent case triaging, quality assurance and clinical trial stratification.